Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Rosetta Genomics Ltd (EM) ROSGQ

Healthcare Biotechnology Diagnostics & Research
Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide. The company’s microRNA technologies based diagnostic tests include RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer; mi-KIDNEY, a kidney tumor classification test for pathology samples; RosettaGX Reveal for the diagnosis of indeterminate thyroid fine-needle aspirate samples; and mi... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (EXPM:ROSGQ)

Rosetta Genomics Reports 2017 Second Quarter and Six Months Financial Results

ACCESS Newswire October 10, 2017

Rosetta Genomics Announces $2 Million Private Placement

ACCESS Newswire September 28, 2017

Rosetta Genomics Enters into Agreement to Sell Its PersonalizeDx Business to Pragmin Prognosis

ACCESS Newswire September 8, 2017

Rosetta Genomics Expands Global Patent Protection for RosettaGX Reveal with Patent Allowance in Japan

ACCESS Newswire September 6, 2017

Rosetta Genomics to Reduce Operating and Other Expenses

ACCESS Newswire September 5, 2017

Major Clinical Reference Laboratory Selects RosettaGX Reveal Thyroid miRNA Classifier as Molecular Test of Choice

ACCESS Newswire August 21, 2017

Rosetta Genomics Announces Pricing of $2.73 Million Financing

ACCESS Newswire August 4, 2017

Clinical Utility Survey Demonstrates the Potential of RosettaGX Reveal(TM) to Significantly Reduce Unnecessary Thyroid Surgeries

ACCESS Newswire July 31, 2017

RosettaGX Reveal(TM) to be Highlighted in Oral Presentation at the 3rd World Congress on Thyroid Cancer

ACCESS Newswire July 26, 2017
View More News ››

Opinion & Analysis (EXPM:ROSGQ)

Stockhouse blogger focuses on out-of-favour biotech stocks (ROSG) (OXGN)

Stockhouse Editorial April 15, 2014
View More Opinion ››

Bullboard Posts (EXPM:ROSGQ)

🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣

<< View Post To Watch Video >>
Roseene - November 19, 2021

🎉📣FSD Pharma's Research and Clinical Advisory Board📢

Dr. Eleanor N. Fish, a world-renowned immunologist and cytokine expert, has been appointed to FSD Pharma's Research and Clinical...
Roseene - November 17, 2021

📣FSD Pharma:Agreement Signed With Covar Pharmaceuticals📢📣

<< View Post To Watch Video >>
Roseene - November 10, 2021

I just can't find much information on rosg.

I'm interested in this stock, but just can't find much information about it.  Does anyone have information on sites that...
rolphie - October 10, 2013

Track your favorite stocks

Stay updated | $ROSG News Analysis Released available at http://www.otcequities.com/sign_up/?sym=HVU
Aaronstockz101 - November 6, 2012

Holding on to ROSG! Gonna Rise like Bread...

Sold ROSG at $5.00 made about 5k today... Got to admit, its a nice gain for a week of holding. I personally dont see ROSG reaching past 5...
ermaer - November 6, 2012
View more Bullboard ››

Oregen Energy Corp

Oregen Energy Corp

Oregen Energy Corp., an energy and resource exploration company, focuses on acquiring and advancing natural resources ...
View More »